Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia

American Journal of Human Genetics

Volumn 73, Issue 2, 2003, Pages 412-419

  Pastore, Yves ^a,b   Jedlickova, Katerina ^b   Guan, Yongli ^b   Liu, Enli ^b   Fahner, James ^c   Hasle, Henrik ^d   Prchal, Jaroslav F ^e   Prchal, Josef T ^a,b,f  

^a TEXAS CHILDREN S CANCER CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HELEN DEVOS CHILDREN S HOSPITAL   (United States)

^d VIBORG HOSPITAL   (Denmark)

^e MCGILL UNIVERSITY   (Canada)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ALLELE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANCER SUSCEPTIBILITY; CHILD; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPOXIA; MALE; MUTATIONAL ANALYSIS; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SIBLING; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0042665948     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/377108     Document Type: Article

References (28)

1. Adryan B, Decker HJ, Papas TS, Hsu T (2000) Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila. Oncogene 19:2803-2811
2. Ang SO, Chen H, Gordeuk VR, Sergueeva AI, Polyakova LA, Miasnikova GY, Kralovics R, Stockton DW, Prchal JT (2002a) Endemic polycythemia in Russia: mutation in the VHL gene. Blood Cells Mol Dis 28:57-62
3. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, Liu E, Sergueeva AI, Miasnikova GY, Mole D, Maxwell PH, Stockton DW, Semenza GL, Prchal JT (2002b) Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32:614-621
4. Bender BU, Eng C, Olschewski M, Berger DP, Laubenberger J, Altehofer C, Kirste G, Orszagh M, van Velthoven V, Miosczka H, Schmidt D, Neumann HP (2001) VHL c.505 T→C mutation confers a high age related penetrance but no increased overall mortality. J Med Genet 38:508-514
5. Bruning T, Weirich G, Hornauer MA, Hofler H, Brauch H (1997) Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene. Arch Toxicol 71:332-335
6. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B (1995) von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 194:629-642
7. Clifford SC, Cockman ME, Smallwood AC, Mole DR, Woodward ER, Maxwell PH, Ratcliffe PJ, Maher ER (2001) Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet 10:1029-1038
8. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54
9. Friedrich CA (2001) Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet 10:763-737
10. Gao J, Naglich JG, Laidlaw J, Whaley JM, Seizinger BR, Kley N (1995) Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene. Cancer Res 55:743-747
11. Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin DJ, Prchal JT, Polyakova LA (2001) High mortality due to thrombosis and cerebral hemorrhage in Chuvash polycythemia. Blood 98:224
12. Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG Jr (2001) von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet 10:1019-1027
13. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr (2001) HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464-468
14. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim AV, Hebestreit HF, Mukherii M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472
15. Knudson AG Jr, Hethcote HW, Brown BW (1975) Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma. Proc Natl Acad Sci USA 72:5116-5120
16. Kralovics R, Josef T, Prchal JT (2001) Genetic heterogeneity of primary familial and congenital polycythemia. Am J Hemat 68:115-121
17. Mankad VN, Moore RB, McRoyan D, Zuckerman K (1987) Erythrocytosis associated with spontaneous erythroid colony formation and idiopathic hypererythropoietinemia. J Pediatr 111:743-745
18. Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP (2002) Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling. Science 296:1886-1889
19. Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V, Kaelin WG (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat Cell Biol 2:423-427
20. Ohh M, Takagi Y, Aso T, Stebbins CE, Pavletich NP, Zbar B, Conaway RC, Conaway JW, Kaelin WG Jr (1999) Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. J Clin Invest 104:1583-1591
21. Pastore YD, Jelinek J, Ang S, Guan Y, Liu E, Jedlickova K, Krishnamurti L, Prchal JT (2003) Mutations in the VHL gene in sporadic apparently congenital polycythemia. Blood 101:1591-1595
22. Percy MJ, McMullin MF, Treacy M, Potter M, Watson WH, Jowitt SN, Lappin TRJ (2002) Identification of the Chuvash-type congenital polycythemia in patients of Asian and Western European ancestry. Blood 100:660
23. Prchal JT. Classification and molecular biology of polycythemias (erythrocytoses) and thrombocytosis. Med Clin North Am (in press)
24. Richards FM, Webster AR, McMahon R, Woodward ER, Rose S, Maher ER (1998) Molecular genetic analysis of von Hippel-Lindau disease. J Intern Med 243:527-533
25. Ritter MM, Frilling A, Crossey PA, Hoppner W, Maher ER, Mulligan L, Ponder BA, D Engelhardt (1996) Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. J Clin Endocrinol Metab 81:1035-1037
26. Semenza GL (2001) HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13:167-171
27. Sergeyeva A, Gordeuk VR, Tokarev YN, Sokol L, Prchal JF, Prchal JT (1997) Congenital polycythemia in Chuvashia. Blood 89:2148-2154
28. Webster AR, Richards FM, MacRonald FE, Moore AT, Maher ER (1998) An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Am J Hum Genet 63:1025-1035